Molekulargenetische Diagnostik
Praxis Dr. Mato Nagel

SREBF1

Das SREBF1-Gen kodiert ein Protein, welches über eine Sterolbindung in die Transkriptionsregulation eingreift. Epigenetische Modifikation in diesem Gen wurde im Zusammenhang mit Fettstoffwechselstörungen beobachtet.

Diagnostik:

Clinic Untersuchungsmethoden Familienuntersuchung
Bearbeitungszeit 5
Probentyp genomic DNA
Research Untersuchungsmethoden Direkte Sequenzierung der proteinkodierenden Bereiche eines Gens
Bearbeitungszeit 25
Probentyp genomic DNA
Clinic Untersuchungsmethoden Hochdurchsatz-Sequenzierung
Bearbeitungszeit 25
Probentyp genomic DNA
Research Untersuchungsmethoden Methylisierungsanalyse
Bearbeitungszeit 25
Probentyp genomic DNA

Krankheiten:

Epigenetische Dyslipidämie
ABCG1
CPT1A
MIR33B
SREBF1
TNIP1
TNNT1

Referenzen:

1.

Lloyd DJ et. al. (2002) A novel interaction between lamin A and SREBP1: implications for partial lipodystrophy and other laminopathies.

[^]
2.

Hua X et. al. (1995) Structure of the human gene encoding sterol regulatory element binding protein-1 (SREBF1) and localization of SREBF1 and SREBF2 to chromosomes 17p11.2 and 22q13.

[^]
3.

Wang X et. al. (1994) SREBP-1, a membrane-bound transcription factor released by sterol-regulated proteolysis.

[^]
4.

Yokoyama C et. al. (1993) SREBP-1, a basic-helix-loop-helix-leucine zipper protein that controls transcription of the low density lipoprotein receptor gene.

[^]
5.

Shimomura I et. al. (1997) Differential expression of exons 1a and 1c in mRNAs for sterol regulatory element binding protein-1 in human and mouse organs and cultured cells.

[^]
6.

Shimano H et. al. (1997) Elevated levels of SREBP-2 and cholesterol synthesis in livers of mice homozygous for a targeted disruption of the SREBP-1 gene.

[^]
7.

Shimomura I et al. (1998) Insulin resistance and diabetes mellitus in transgenic mice expressing nuclear SREBP-1c in adipose tissue: model for congenital generalized lipodystrophy.

[^]
8.

DeBose-Boyd RA et. al. (1999) Transport-dependent proteolysis of SREBP: relocation of site-1 protease from Golgi to ER obviates the need for SREBP transport to Golgi.

[^]
9.

Shimomura I et al. (2000) Decreased IRS-2 and increased SREBP-1c lead to mixed insulin resistance and sensitivity in livers of lipodystrophic and ob/ob mice.

[^]
10.

None (2001) CREating a SCAP-less liver keeps SREBPs pinned in the ER membrane and prevents increased lipid synthesis in response to low cholesterol and high insulin.

[^]
11.

Tobe K et al. (2001) Increased expression of the sterol regulatory element-binding protein-1 gene in insulin receptor substrate-2(-/-) mouse liver.

[^]
12.

Nagata R et. al. (2004) Single nucleotide polymorphism (-468 Gly to A) at the promoter region of SREBP-1c associates with genetic defect of fructose-induced hepatic lipogenesis [corrected].

[^]
13.

Lin J et. al. (2005) Hyperlipidemic effects of dietary saturated fats mediated through PGC-1beta coactivation of SREBP.

[^]
14.

Bengoechea-Alonso MT et. al. (2005) Hyperphosphorylation regulates the activity of SREBP1 during mitosis.

[^]
15.

Yang F et. al. (2006) An ARC/Mediator subunit required for SREBP control of cholesterol and lipid homeostasis.

[^]
16.

Taghibiglou C et. al. (2009) Role of NMDA receptor-dependent activation of SREBP1 in excitotoxic and ischemic neuronal injuries.

[^]
17.

Najafi-Shoushtari SH et. al. (2010) MicroRNA-33 and the SREBP host genes cooperate to control cholesterol homeostasis.

[^]
18.

Cui G et. al. (2011) Liver X receptor (LXR) mediates negative regulation of mouse and human Th17 differentiation.

[^]
19.

Han J et. al. (2015) The CREB coactivator CRTC2 controls hepatic lipid metabolism by regulating SREBP1.

[^]
20.

Braun KV et. al. (2016) The role of DNA methylation in dyslipidaemia: A systematic review.

[^]
21.

Pfeiffer L et. al. (2015) DNA methylation of lipid-related genes affects blood lipid levels.

[^]

 

 
Ihre Nachricht: